Core Points - The company is appointing Zhengdan Zhiyuan (Shenzhen) CPA Firm to audit the revised 2023 financial statements due to a change in profit and loss status from profit to loss as per the regulatory requirements [4][10] - The board of directors has approved the appointment of the CPA firm with a unanimous vote and is now seeking shareholder approval [10][12] Group 1: Appointment of CPA Firm - The CPA firm Zhengdan Zhiyuan (Shenzhen) was selected based on its qualifications and ability to meet the company's auditing needs for the revised financial statements [9][10] - The firm has a history of providing auditing services, with 16 listed company clients in 2024, including 13 in manufacturing and 2 in information technology [6][9] - The firm has no recent criminal or administrative penalties, indicating a strong compliance record [7][8] Group 2: Board of Directors' Actions - The board has nominated Mr. Wang Qingtang as a candidate for a non-independent director position, pending shareholder approval [12] - The nomination is part of the company's efforts to enhance its corporate governance structure [12] - Mr. Wang has relevant experience and qualifications, having served in various roles within the company since 2006 [13]
ST葫芦娃: 海南葫芦娃药业集团股份有限公司2025年第一次临时股东大会会议资料